Business Context and Reporting Period
This Form 8-K was filed by Obalon Therapeutics, Inc. on June 5, 2018. The filing reports on a material definitive agreement entered into on June 1, 2018, regarding the amendment of the company's office lease for its corporate headquarters in Carlsbad, California.
Key Financial Metrics
The filing details a new financial obligation related to real estate but does not report revenue, profit, cash flow, or margins.
- Total Lease Payments: Approximately $1.9 million over the lease term.
- Lease Term: Extended from March 31, 2019, to March 31, 2022.
- Base Rent (Effective June 15, 2018): Increased from $30,643 to $35,773 per month.
- Maximum Base Rent (Effective June 2021): $39,024 per month.
- Common Area Operating Expenses: $3,030 per month.
- Tenant Improvement Allowance: Up to $121,200.
- Leased Space: Increased from 17,500 to 20,200 square feet.
Material Changes
The primary material change is the expansion of the company's physical footprint and the extension of its lease commitment.
- Space Expansion: The company is leasing an additional 2,700 square feet in an adjacent building.
- Term Extension: The lease expiration date has been pushed back by three years to March 31, 2022.
- Cost Increase: Monthly fixed costs (base rent plus operating expenses) will increase by approximately $8,160 per month starting in mid-June 2018.
Outlook, Risks, and Contingencies
The filing does not provide forward-looking guidance, management commentary on financial performance, or specific risk factors beyond the commitment to the new lease terms.
- Commitment: The company has no right or option to extend the lease term after March 31, 2022.
- Usage of Funds: The tenant improvement allowance is restricted to repairs, maintenance, and mutually agreed-upon improvements.
Investor Verification Checklist
- Verify the impact of the increased monthly rent ($35,773 + $3,030) on the company's current cash burn rate.
- Confirm the status of the $121,200 tenant improvement allowance and whether it has been fully utilized.
- Review the full text of Exhibit 10.1 (Fourth Amendment to Lease) for any termination clauses or penalties not summarized in this report.
- Assess whether the additional 2,700 square feet aligns with current headcount growth or future hiring plans.